Robert B. Chess

2006

In 2006, Robert B. Chess earned a total compensation of $2.4M as Former Acting President and Chief Executive Officer at Nektar Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$262,718
Option Awards$1,011,709
Salary$418,459
Stock Awards$716,224
Other$8,040
Total$2,417,150

Chess received $1M in option awards, accounting for 42% of the total pay in 2006.

Chess also received $262.7K in non-equity incentive plan, $418.5K in salary, $716.2K in stock awards and $8K in other compensation.

Rankings

In 2006, Robert B. Chess' compensation ranked 1,413th out of 7,022 executives tracked by ExecPay. In other words, Chess earned more than 79.9% of executives.

ClassificationRankingPercentile
All
1,413
out of 7,022
80th
Division
Manufacturing
443
out of 2,413
82nd
Major group
Chemicals And Allied Products
79
out of 673
88th
Industry group
Drugs
43
out of 518
92nd
Industry
Pharmaceutical Preparations
36
out of 355
90th
Source: SEC filing on April 28, 2008.

Chess' colleagues

We found six more compensation records of executives who worked with Robert B. Chess at Nektar Therapeutics in 2006.

2006

Ajit Gill

Nektar Therapeutics

Chief Executive Officer

2006

Ajay Bansal

Nektar Therapeutics

Chief Financial Officer

2006

John Patton

Nektar Therapeutics

Chief Research Fellow

2006

David Johnston

Nektar Therapeutics

Former Senior Vice President Research and Development

2006

Louis Drapeau

Nektar Therapeutics

Chief Financial Officer

2006

Nevan Elam

Nektar Therapeutics

Senior Vice President and Head of the Pulmonary Business Unit

You may also like